Literature DB >> 26561000

Transcription factor-mediated reprograming of fibroblasts to hepatocyte-like cells.

Behshad Pournasr1, Mohammad Hassan Asghari-Vostikolaee2, Hossein Baharvand3.   

Abstract

Direct conversion by overexpression of defined transcription factors (TFs) is a promising new method that can generate desired cell types from abundant, accessible cells. While previous studies have reported hepatic generation from fibroblasts, tremendous interest exists in the understanding of hepatic reprograming and its applicability in regenerative medicine. Here, we show that overexpression of Yamanaka factors can induce reprograming of mouse fibroblasts into cells that closely resemble hepatocytes in vitro in the presence of an optimized hepatic growth medium. By screening the effects of 20 candidate transcription factors, we identified a combination of three TFs (Hnf4a, Cebpa, and Nr1i2) that can convert fibroblasts into a hepatic fate. These factors in conjunction with Yamanaka factors increase the efficiency of hepatic reprograming. The induced hepatocyte-like (iHep) cells have multiple hepatocyte-specific characteristics; express hepatocyte-specific markers, glycogen storage, albumin secretion, urea production, as well as low-density lipoprotein and indocyanin green uptake. Production of iHep cells by these novel approaches may bring new insights into the molecular nature of hepatocyte differentiation and future cell-based therapeutics for liver diseases.
Copyright © 2015 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Direct conversion; Hepatic-specific transcription factors; Hepatocyte-like cells; Yamanaka factors

Mesh:

Substances:

Year:  2015        PMID: 26561000     DOI: 10.1016/j.ejcb.2015.10.003

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  8 in total

Review 1.  Computational methods for direct cell conversion.

Authors:  Uma S Kamaraj; Julian Gough; Jose M Polo; Enrico Petretto; Owen J L Rackham
Journal:  Cell Cycle       Date:  2016-10-13       Impact factor: 4.534

2.  Periodic acid‑Schiff staining method for function detection of liver cells is affected by 2% horse serum in induction medium.

Authors:  Hui Hui; Wenjun Ma; Jiejie Cui; Mengjia Gong; Yi Wang; Yuanyuan Zhang; Tongchuan He; Yang Bi; Yun He
Journal:  Mol Med Rep       Date:  2017-09-22       Impact factor: 2.952

Review 3.  Reprogramming cell fates by small molecules.

Authors:  Xiaojie Ma; Linghao Kong; Saiyong Zhu
Journal:  Protein Cell       Date:  2017-02-17       Impact factor: 14.870

4.  Phenotype instability of hepatocyte-like cells produced by direct reprogramming of mesenchymal stromal cells.

Authors:  Iasmim Diniz Orge; Victoria L Gadd; Judah Leão Barouh; Erik Aranha Rossi; Rejane Hughes Carvalho; Ian Smith; Kyan James Allahdadi; Bruno Diaz Paredes; Daniela Nascimento Silva; Patrícia Kauanna F Damasceno; Gabriela Louise Sampaio; Stuart J Forbes; Milena Botelho Pereira Soares; Bruno Solano de Freitas Souza
Journal:  Stem Cell Res Ther       Date:  2020-04-10       Impact factor: 6.832

5.  Oct4 and Hnf4α-induced hepatic stem cells ameliorate chronic liver injury in liver fibrosis model.

Authors:  Myung Rae Park; Man Sze Wong; Marcos J Araúzo-Bravo; Hyunah Lee; Donggyu Nam; Soo Yong Park; Hong Dae Seo; Sang Min Lee; Hans Florian Zeilhofer; Holm Zaehres; Hans R Schöler; Jeong Beom Kim
Journal:  PLoS One       Date:  2019-08-12       Impact factor: 3.240

Review 6.  Alternative Cell Sources for Liver Parenchyma Repopulation: Where Do We Stand?

Authors:  Tine Tricot; Jolan De Boeck; Catherine Verfaillie
Journal:  Cells       Date:  2020-02-28       Impact factor: 6.600

7.  Phenotypical, functional and transcriptomic comparison of two modified methods of hepatocyte differentiation from human induced pluripotent stem cells.

Authors:  Rong Li; Yang Zhao; Jeffrey J Yourick; Robert L Sprando; Xiugong Gao
Journal:  Biomed Rep       Date:  2022-03-23

Review 8.  In Vitro Generated Hepatocyte-Like Cells: A Novel Tool in Regenerative Medicine and Drug Discovery.

Authors:  Kobra Zakikhan; Behshad Pournasr; Massoud Vosough; Marjan Nassiri-Asl
Journal:  Cell J       Date:  2017-02-22       Impact factor: 2.479

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.